TUG-1375 is primarily utilized in the field of medical research, particularly in the development of treatments for various cancers. It functions as a potent inhibitor of certain enzymes that are crucial for the survival and proliferation of cancer cells. By targeting these enzymes, TUG-1375 effectively disrupts the signaling pathways that cancer cells rely on, leading to their inhibition and potential cell death. This makes it a valuable compound in preclinical studies aimed at understanding cancer biology and evaluating the efficacy of new therapeutic strategies. Additionally, TUG-1375 is being explored for its potential use in combination therapies, where it may enhance the effectiveness of other anticancer drugs, offering a more comprehensive approach to cancer treatment.